Rozerem (Takeda Pharmaceuticals America, Inc.)


Welcome to the PulseAid listing for the Rozerem drug offered from Takeda Pharmaceuticals America, Inc.. This Melatonin Receptor Agonist [EPC],Melatonin Receptor Agonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Takeda Pharmaceuticals America, Inc.
NON-PROPRIETARY NAME: ramelteon
SUBSTANCE NAME: RAMELTEON
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Melatonin Receptor Agonist [EPC],Melatonin Receptor Agonists [MoA]
ROUTE: ORAL
DOSAGE FORM: TABLET, FILM COATED
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2005-07-22
END MARKETING DATE: 0000-00-00


Rozerem HUMAN PRESCRIPTION DRUG Details:

Item DescriptionRozerem from Takeda Pharmaceuticals America, Inc.
LABELER NAME: Takeda Pharmaceuticals America, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 8(mg/1)
START MARKETING DATE: 2005-07-22
END MARKETING DATE: 0000-00-00
PRODUCT ID: 64764-805_74e295ed-af9b-4d5d-9505-ec565c56e9ea
PRODUCT NDC: 64764-805
APPLICATION NUMBER: NDA021782

Other RAMELTEON Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Avera McKennan HospitalRozerem
Bryant Ranch PrepackRozerem
Physicians Total Care, Inc.Rozerem
Rebel Distributors CorpRozerem
Takeda Pharmaceuticals America, Inc.Rozerem